Globus Medical, Inc. (GMED)
USD 81.78
(-1.97%)
USD 81.78
(-1.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 243.49 Million | 178.46 Million | 276.27 Million | 198.79 Million | 171.97 Million | 181.64 Million |
| Net Income | 122.87 Million | 190.16 Million | 149.19 Million | 102.28 Million | 155.21 Million | 156.47 Million |
| Depreciation & Amortization | 144.73 Million | 68.25 Million | 69.86 Million | 62.87 Million | 52.73 Million | 41.63 Million |
| Deferred income taxes | -57.78 Million | -22.22 Million | -17.61 Million | -4.33 Million | 4.3 Million | 971 Thousand |
| Stock-based compensation | 52.74 Million | 32.81 Million | 30.58 Million | 27.07 Million | 26.08 Million | 21.89 Million |
| Change in working capital | -116.59 Million | -105.26 Million | -17.25 Million | -37.59 Million | -73.44 Million | -49.86 Million |
| Other non-cash items | 97.53 Million | 14.72 Million | 61.49 Million | 48.48 Million | 7.08 Million | 10.53 Million |
| Investing Cash Flow | 302.96 Million | -110.36 Million | -375.93 Million | -117.32 Million | -140.28 Million | -193.02 Million |
| Investments in PPE | -78.27 Million | -74.04 Million | -56.89 Million | -63.65 Million | -70.75 Million | -59.69 Million |
| Acquisitions | -296.02 Million | -31.43 Million | -34.48 Million | -33.48 Million | -23.79 Million | -14.82 Million |
| Investment purchases | -100.64 Million | -419.53 Million | -622.35 Million | -223.54 Million | -346.52 Million | -537.94 Million |
| Sales/Maturities of investments | 777.91 Million | 414.65 Million | 337.8 Million | 203.35 Million | 300.79 Million | 384.43 Million |
| Other Investing Activities | 677.27 Million | -4.88 Million | -284.55 Million | -20.18 Million | -45.73 Million | 35 Million |
| Financing Cash Flow | -231.82 Million | -109.96 Million | 54.14 Million | -38.66 Million | 24.43 Million | 32.57 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -225.56 Million | -144.49 Million | - | -104.66 Million | - | - |
| Common Stock Issuance | 12.39 Million | 41.71 Million | 63.49 Million | 72.32 Million | 31.03 Million | 39.3 Million |
| Other Financing Activities | -18.65 Million | -7.18 Million | -9.34 Million | -6.31 Million | -6.59 Million | -6.73 Million |
| Accounts receivables | -49.91 Million | -50.84 Million | -25.89 Million | 10.69 Million | -18.3 Million | -21.78 Million |
| Accounts payables | -14.22 Million | 14.41 Million | 3.68 Million | -6.35 Million | 773 Thousand | -3 Million |
| Inventory | -70.32 Million | -61.74 Million | -11.97 Million | -50.11 Million | -50.01 Million | -31.38 Million |
| Other working capital | 17.86 Million | -7.09 Million | 16.93 Million | 8.17 Million | -5.89 Million | 6.31 Million |
| Cash at beginning of period | 150.46 Million | 193.06 Million | 239.39 Million | 195.72 Million | 139.74 Million | 118.81 Million |
| Cash at end of period | 467.29 Million | 150.46 Million | 193.06 Million | 239.39 Million | 195.72 Million | 139.74 Million |
| Capital Expenditure | -78.27 Million | -74.04 Million | -56.89 Million | -63.65 Million | -70.75 Million | -59.69 Million |
| Effect of forex changes on cash | 2.18 Million | -747 Thousand | -810 Thousand | 865 Thousand | -156 Thousand | -256 Thousand |
| Net cash flow / Change in cash | 316.82 Million | -42.6 Million | -46.32 Million | 43.67 Million | 55.97 Million | 20.93 Million |
| Free Cash Flow | 165.22 Million | 104.42 Million | 219.37 Million | 135.13 Million | 101.22 Million | 121.94 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 51.83 Million | 31.76 Million | -7.11 Million | 15.03 Million | 122.87 Million | 998 Thousand |
| Depreciation & Amortization | 66.82 Million | 63.58 Million | 55.26 Million | 71.16 Million | 144.73 Million | 37.38 Million |
| Deferred income taxes | -27.44 Million | -20.18 Million | -45.09 Million | -11.79 Million | -57.78 Million | -34.83 Million |
| Stock-based compensation | 12.21 Million | 12.81 Million | 17.26 Million | 12.44 Million | 52.74 Million | 22.75 Million |
| Change in working capital | 159.67 Million | -116.95 Million | -42.71 Million | -45.4 Million | -116.59 Million | -1.59 Million |
| Other non-cash items | -59.44 Million | 307.59 Million | 253.7 Million | 63.23 Million | 97.53 Million | 25.76 Million |
| Investing Cash Flow | -14.96 Million | -10.37 Million | -46.58 Million | 320.61 Million | 302.96 Million | -80.86 Million |
| Investments in PPE | -41.95 Million | -27.79 Million | -28.56 Million | -22.88 Million | -78.27 Million | -21.53 Million |
| Acquisitions | 26.14 Million | -4.88 Million | -12.64 Million | 309.73 Million | -296.02 Million | -293.36 Million |
| Investment purchases | -1.19 Million | -4.15 Million | -8.01 Million | - | -100.64 Million | -19.26 Million |
| Sales/Maturities of investments | 28.27 Million | 26.46 Million | 2.65 Million | 343.49 Million | 777.91 Million | 253.3 Million |
| Other Investing Activities | -26.24 Million | 22.3 Million | -5.36 Million | 343.49 Million | 677.27 Million | 234.03 Million |
| Financing Cash Flow | 19.58 Million | 8.7 Million | -115.72 Million | -237.27 Million | -231.82 Million | 1.42 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.47 Million | -83.31 Million | -225.56 Million | -225.56 Million | - |
| Common Stock Issuance | -17.65 Million | 14.23 Million | 3.41 Million | 1.04 Million | 12.39 Million | 3.29 Million |
| Other Financing Activities | 37.23 Million | -4.05 Million | -35.81 Million | -12.74 Million | -18.65 Million | -1.87 Million |
| Accounts receivables | 23.66 Million | -87.81 Million | -36.39 Million | -12.96 Million | -49.91 Million | -8.71 Million |
| Accounts payables | -10.26 Million | 17.31 Million | -5.75 Million | -6.27 Million | -14.22 Million | -5.18 Million |
| Inventory | 4.88 Million | -13.86 Million | -8.98 Million | -11.35 Million | -70.32 Million | -20.32 Million |
| Other working capital | 24.17 Million | -32.58 Million | 8.41 Million | -14.81 Million | 17.86 Million | 32.62 Million |
| Cash at beginning of period | 410.42 Million | 354.06 Million | 467.29 Million | 279.62 Million | 150.46 Million | 306.45 Million |
| Cash at end of period | 622.76 Million | 410.42 Million | 354.06 Million | 467.29 Million | 467.29 Million | 279.62 Million |
| Capital Expenditure | -41.95 Million | -27.79 Million | -28.56 Million | -22.88 Million | -78.27 Million | -21.53 Million |
| Effect of forex changes on cash | 4.07 Million | 3.77 Million | -3.31 Million | -347 Thousand | 2.18 Million | 2.12 Million |
| Net cash flow / Change in cash | 212.34 Million | 56.36 Million | -113.23 Million | 187.67 Million | 316.82 Million | -26.83 Million |
| Free Cash Flow | 161.7 Million | 26.46 Million | 23.81 Million | 81.79 Million | 165.22 Million | 28.95 Million |
UKW
BHP
ELIC
SCN
KRC
NASO